These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11036194)

  • 1. Cutaneous nerve degeneration induced by acrylamide in mice.
    Ko MH; Chen WP; Hsieh ST
    Neurosci Lett; 2000 Nov; 293(3):195-8. PubMed ID: 11036194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathology of skin denervation in acrylamide-induced neuropathy.
    Ko MH; Chen WP; Hsieh ST
    Neurobiol Dis; 2002 Oct; 11(1):155-65. PubMed ID: 12460555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent acrylamide neurotoxicity in mice: morphology, physiology, and function.
    Ko MH; Chen WP; Lin-Shiau SY; Hsieh ST
    Exp Neurol; 1999 Jul; 158(1):37-46. PubMed ID: 10448416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of nerve terminal degeneration in the skin.
    Hsieh ST; Chiang HY; Lin WM
    J Neuropathol Exp Neurol; 2000 Apr; 59(4):297-307. PubMed ID: 10759185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy.
    Fischer LR; Li Y; Asress SA; Jones DP; Glass JD
    Exp Neurol; 2012 Jan; 233(1):163-71. PubMed ID: 21963651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rat caudal nerves: a model for experimental neuropathies.
    Schaumburg HH; Zotova E; Raine CS; Tar M; Arezzo J
    J Peripher Nerv Syst; 2010 Jun; 15(2):128-39. PubMed ID: 20626776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve terminals as the primary site of acrylamide action: a hypothesis.
    LoPachin RM; Ross JF; Lehning EJ
    Neurotoxicology; 2002 May; 23(1):43-59. PubMed ID: 12164547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acrylamide axonopathy revisited.
    LoPachin RM; Balaban CD; Ross JF
    Toxicol Appl Pharmacol; 2003 May; 188(3):135-53. PubMed ID: 12729714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in brainstem and spinal cord.
    Lehning EJ; Balaban CD; Ross JF; LoPachin RM
    Neurotoxicology; 2003 Jan; 24(1):109-23. PubMed ID: 12564387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in brainstem and spinal cord.
    Lehning EJ; Balaban CD; Ross JF; LoPachi RM
    Neurotoxicology; 2002 Sep; 23(3):415-29. PubMed ID: 12387367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cutaneous nerves on keratinocyte proliferation and epidermal thickness in mice.
    Huang IT; Lin WM; Shun CT; Hsieh ST
    Neuroscience; 1999; 94(3):965-73. PubMed ID: 10579589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative pathology of cutaneous nerve terminal degeneration in the human skin.
    Chien HF; Tseng TJ; Lin WM; Yang CC; Chang YC; Chen RC; Hsieh ST
    Acta Neuropathol; 2001 Nov; 102(5):455-61. PubMed ID: 11699558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):300-20. PubMed ID: 190358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrylamide neuropathy. III. Spatiotemporal characteristics of nerve cell damage in forebrain.
    Lehning EJ; Balaban CD; Ross JF; LoPachin RM
    Neurotoxicology; 2003 Jan; 24(1):125-36. PubMed ID: 12564388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological studies of toxic distal axonopathy.
    Schaumburg HH
    Neurobehav Toxicol; 1979; 1 Suppl 1():187-8. PubMed ID: 299577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does acrylamide perturb axon transport and induce nerve fiber degeneration? Commentary on forum position paper.
    Sabri MI; Spencer PS
    Neurotoxicology; 2002 Jul; 23(2):259-63; discussion 265-70. PubMed ID: 12224766
    [No Abstract]   [Full Text] [Related]  

  • 17. Nervous system degeneration produced by acrylamide monomer.
    Spencer PS; Schaumburg HH
    Environ Health Perspect; 1975 Jun; 11():129-33. PubMed ID: 170076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal arbor degeneration--a novel lesion produced by the antineoplastic agent paclitaxel.
    Bennett GJ; Liu GK; Xiao WH; Jin HW; Siau C
    Eur J Neurosci; 2011 May; 33(9):1667-76. PubMed ID: 21395870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional difference in epidermal thinning after skin denervation.
    Chiang HY; Huang IT; Chen WP; Chien HF; Shun CT; Chang YC; Hsieh ST
    Exp Neurol; 1998 Nov; 154(1):137-45. PubMed ID: 9875275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous innervation in Guillain-Barré syndrome: pathology and clinical correlations.
    Pan CL; Tseng TJ; Lin YH; Chiang MC; Lin WM; Hsieh ST
    Brain; 2003 Feb; 126(Pt 2):386-97. PubMed ID: 12538405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.